Semaglutide in Canada — The Complete 2026 Guide
Semaglutide in Canada is entering a new era. With data exclusivity expiring on January 4, 2026 and nine generic applications under review, Canadians could see dramatically lower prices for Ozempic, Wegovy, and Rybelsus alternatives by late 2026.
Read More north_east